Skip to main content

Week In Review: RemeGen, A Yantai Biologics Company, Completes $515 Million Hong Kong IPO

RemeGen completed a $515 million IPO on the Hong Kong exchange in the largest biotech IPO of the year. The company's shares have traded 34% higher since the IPO, giving RemeGen a market capitalization of $4.3 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.